murray valley encephalitis virus
Recently Published Documents


TOTAL DOCUMENTS

105
(FIVE YEARS 4)

H-INDEX

26
(FIVE YEARS 1)

Viruses ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 147
Author(s):  
Daniel Westlake ◽  
Helle Bielefeldt-Ohmann ◽  
Natalie A. Prow ◽  
Roy A. Hall

Alfuy (ALFV) is an attenuated flavivirus related to the Murray Valley encephalitis virus (MVEV). We previously identified markers of attenuation in the envelope (E) protein of the prototype strain (ALFV3929), including the hinge region (E273–277) and lack of glycosylation at E154-156. To further determine the mechanisms of attenuation we assessed ALFV3929 binding to glycosaminoglycans (GAG), a known mechanism of flaviviruses attenuation. Indeed, ALFV3929 exhibited reduced binding to GAG-rich cells in the presence of heparin; however, low-passage ALFV isolates were relatively unaffected. Sequence comparisons between ALFV strains and structural modelling incriminated a positively-charged residue (K327) in ALFV3929 as a GAG-binding motif. Substitution of this residue to the corresponding uncharged residue in MVEV (L), using a previously described chimeric virus containing the prM & E genes of ALFV3929 in the backbone of MVEV (MVEV/ALFV-prME), confirmed a role for K327 in enhanced GAG binding. When the wild type residues at E327, E273–277 and E154–156 of ALFV3929 were replaced with the corresponding residues from virulent MVEV, it revealed each motif contributed to attenuation of ALFV3929, with the E327/E273–277 combination most dominant. These data demonstrate that attenuation of ALFV3929 is multifactorial and provide new insights for the rational design of attenuated flavivirus vaccines.


2019 ◽  
Vol 211 (11) ◽  
pp. 499 ◽  
Author(s):  
Leon Caly ◽  
Natalie Davidson ◽  
Ram Ghimire ◽  
Brinthan Rajaratnam ◽  
Jonathan Marrow ◽  
...  

Viruses ◽  
2018 ◽  
Vol 10 (6) ◽  
pp. 319 ◽  
Author(s):  
Jessica Russell ◽  
Leon Caly ◽  
Renata Kostecki ◽  
Sarah McGuinness ◽  
Glen Carter ◽  
...  

2018 ◽  
Vol 3 (2) ◽  
pp. 49 ◽  
Author(s):  
John Floridis ◽  
Sarah McGuinness ◽  
Nina Kurucz ◽  
Jim Burrow ◽  
Rob Baird ◽  
...  

2018 ◽  
Vol 39 (2) ◽  
pp. 106
Author(s):  
David T Williams

Of the viruses transmitted by mosquitoes in the Australasian region, Murray Valley encephalitis (MVE) virus is the major cause of brain disease in humans. There is no vaccine to prevent MVE, nor are there effective antiviral drugs available to treat infections. Therefore, surveillance of MVE is essential to control efforts. A key element to this is understanding the virus at a genetic level, which allows the tracking and identification of known or novel genetic types and can tell us about their circulation patterns.


2018 ◽  
Vol 39 (2) ◽  
pp. 99
Author(s):  
Tristan Gibbs ◽  
David J Speers

The Flavivirus genus contains dozens of species with varying geographical distributions. Most flavivirus infections in humans are asymptomatic or manifest as a non-specific febrile illness, sometimes accompanied by rash or arthralgia. Certain species are more commonly associated with neurological disease and may be termed neurotropic flaviviruses. Several flaviviruses endemic to Australia and our near northern neighbours are neurotropic, such as Murray Valley encephalitis virus, West Nile (Kunjin) virus and Japanese encephalitis virus. Flavivirus neurological disease ranges from self-limiting meningitis to fulminant encephalitis causing permanent debilitating neurological sequelae or death. The recent Zika virus outbreak in South America has highlighted the dramatic effects of flavivirus neurotropism on the developing brain. This article focuses on the neurotropic flaviviruses endemic to Australia and those of international significance.


2017 ◽  
Vol 23 (2) ◽  
pp. 280-283 ◽  
Author(s):  
Daniel J. Niven ◽  
Kevin Afra ◽  
Mircea Iftinca ◽  
Raymond Tellier ◽  
Kevin Fonseca ◽  
...  

2017 ◽  
Vol 23 (2) ◽  
Author(s):  
Daniel J. Niven ◽  
Kevin Afra ◽  
Mircea Iftinca ◽  
Raymond Tellier ◽  
Kevin Fonseca ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document